Shasqi presented three posters at the 2023 American Association for Cancer Research (AACR) Annual Meeting in April 2023 in Orlando, Florida.

View the abstracts below:

CAPAC a modular platform that can improve the safety and efficacy of existing cancer therapies, SQ3370

SQ3370, a doxorubicin-based click chemistry therapeutic, promotes a shift from an immunosuppressive towards a T-cell permissive tumor microenvironment in patients

A click chemistry-activated auristatin protodrug (SQP22) demonstrates potency and safety with antibody and intratumoral tumor-targeting agents

‍

‍